Edition:
United States

Shanghai Fosun Pharmaceutical Group Co Ltd (600196.SS)

600196.SS on Shanghai Stock Exchange

23.22CNY
9 Dec 2016
Change (% chg)

¥0.04 (+0.17%)
Prev Close
¥23.18
Open
¥23.28
Day's High
¥23.36
Day's Low
¥23.12
Volume
5,862,258
Avg. Vol
10,572,393
52-wk High
¥25.77
52-wk Low
¥16.50

600196.SS

Chart for 600196.SS

About

Shanghai Fosun Pharmaceutical (Group) Co., Ltd is a China-based company engaged in research, development, production and sale of pharmaceuticals. The Company's products are mainly used in the treatment of metabolism and digestive tract system, cardiovascular system, central nervous system, blood system and anti-infection... (more)

Overall

Beta: 0.70
Market Cap(Mil.): ¥55,257.17
Shares Outstanding(Mil.): 2,414.51
Dividend: 0.32
Yield (%): 1.38

Financials

  600196.SS Industry Sector
P/E (TTM): 19.62 29.74 30.35
EPS (TTM): 1.18 -- --
ROI: 12.33 15.90 15.27
ROE: 14.77 17.00 16.60

BRIEF-Shanghai Fosun Pharma's vice president resigns due to personal reasons

Nov 29 Shanghai Fosun Pharmaceutical Group Co Ltd

Nov 29 2016

BRIEF-Shanghai Fosun Pharmaceutical Group unit gets GMP certificate

Nov 25 Shanghai Fosun Pharmaceutical Group Co Ltd :

Nov 25 2016

BRIEF-Shanghai Fosun Pharma's controlling shareholder increases shareholdings in the company

Nov 17 Shanghai Fosun Pharmaceutical Group Co Ltd

Nov 17 2016

BRIEF-Shanghai Fosun's controlling shareholder has added 5.5 mln A-shares in the company

Nov 10 Shanghai Fosun Pharmaceutical Group Co Ltd

Nov 10 2016

BRIEF-Shanghai Fosun Pharmaceutical Group unit signs exclusive license for monoclonal antibody product KTN0216

* Says its subsidiary Shanghai Henlius Biotech, Inc. signed a exclusive license of intellectual property rights and commercialization rights in China, Singapore, Malaysia, Thailand, the Philippines, Indonesia and several Southeast Asian countries for monoclonal antibody product KTN0216 and its derivative products with Kolltan Pharmaceuticals, Inc.

Nov 03 2016

BRIEF-Shanghai Fosun Pharma's 9-month net profit up 15.1 pct

Oct 28 Shanghai Fosun Pharmaceutical Group Co Ltd

Oct 28 2016

Earnings vs. Estimates